Literature DB >> 17895799

Preoperative evaluation of lower extremity arteries for free fibula transfer using MDCT angiography.

Kwang Nam Jin1, Whal Lee, Yong Hu Yin, Sang-Il Choi, Hwan Jun Jae, Jin Wook Chung, Jae Hyung Park.   

Abstract

OBJECTIVE: We discuss the preoperative application of computed tomographic (CT) angiography to identify legs suitable for free fibular flaps.
METHODS: The condition of 118 consecutive patients was prospectively evaluated by means of CT angiography for planned free fibula flap reconstructions. We retrospectively investigated whether fibular free flap transfer was performed in candidate patients and whether the presence of postoperative foot ischemia had been followed.
RESULTS: Multidetector row CT angiography demonstrated a normal arterial anatomy in 82 patients, anatomical variants in 30 patients, and peripheral arterial occlusive disease in 6 patients. The radiologists selected 20 legs as major variants that cannot ensure lower extremity viability after flap harvest. Sixty-three patients underwent fibula free flap transfer. The surgeons followed our imaging diagnosis and selected healthy legs as candidates for fibular free transfer in all but 2 patients. No postoperative foot ischemia presented in any patient.
CONCLUSIONS: Computed tomographic angiography is a reliable preoperative imaging technique for the selection of appropriate legs as candidates for fibular free transfer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17895799     DOI: 10.1097/RCT.0b013e318033defd

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  2 in total

1.  A case of heel reconstruction with a reverse sural artery flap in a hemophilia B patient.

Authors:  Byung Kwon Lee; Jeong Su Shim
Journal:  Arch Plast Surg       Date:  2012-03-14

2.  Preoperative Angiography for Free Fibula Flap Harvest: A Case Series.

Authors:  Noor Alolabi; Haley Augustine; Forough Farrokhyar; Carolyn Levis
Journal:  Plast Surg (Oakv)       Date:  2021-05-05       Impact factor: 0.558

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.